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Abstract
Background and Objectives: Perforation is a rare complication of gastric carcinoma and
generally not diagnosed preoperatively. To clarify the clinicopathologic characteristics of patients
with this condition we reviewed 13 cases of gastric cancer perforation who required emergency
surgery.
Methods: A total of 13 patients with gastric cancer perforation were retrospectively reviewed.
The clinicopathological features including tumor stage and survival and also the type of treatment
were analyzed and compared to literature data.
Results: There were 13 patients (10 males and 3 females) with a mean age of 59.0 ± 9.56 years.
The incidence of perforated gastric cancer was 9.6% among gastric carcinoma and 4.2% of all gastric
perforation cases. The perforation was more frequently in stage III–IV (2–10), but one case of stage
II (T3N0M0) gastric cancer was also observed. None of the patients had curative resection or
radical lymph-node dissection. Six (46%) patients were treated by palliative, local surgery.
Emergency gastrectomy were performed in 7 (54%) patients. Overall 30-day mortality rate was %
46. The overall survival time was 128.2 ± 184.8 days for all patients, it was 52.8 ± 52.9 days for
locally treated group, and 192.9 ± 235.4 days for patients who underwent resectional surgery. The
difference between the treatment groups was not significant
Conclusion: Perforation usually occurs in advanced stages of gastric cancer. These patients had a
poor prognosis because of the presence of advanced cancer.
Introduction
Oncologic emergencies in patients with gastric cancer
include perforation and major bleeding. These complica-
tions require emergency treatment and have a high mor-
tality rate[1,2]. Perforated gastric cancer (PGC) is a rare
condition with a reported incidence of 0.3–3.9%, and
generally present with histories and symptoms that do not
differ obviously from those of benign gastric perforation
[1-5]. In most instances, gastric carcinoma is not sus-
pected as the cause of perforation prior to emergency
laparotomy [6]. Even during surgery the gastric ulcer is
often difficult to be characterized as benign or malignant
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by the surgeon, especially when a frozen section is una-
vailable [6,7].
Since PGC is clinically characterized by generalized peri-
tonitis and frequently occurs at an advanced stage of the
disease, it usually results in a poor outcome, and long-
term survival seems to be rare [4,8].
The treatment should aim to manage both the emergency
condition of peritonitis and the oncologic technical
aspects of surgery.
Factors influencing the surgical results and recommended
treatment strategies are unclear.
The aim of this study is to address these questions by ana-
lyzing a series of 13 patients who were treated for perfo-
rated, advanced stage adenocarcinoma of the stomach
over the last 8 years.
Patients and methods
This work is a retrospectively descriptive study of perfo-
rated gastric cancer. We reviewed the medical records of
13 patients with PGC who had undergone surgical treat-
ment in the Yuzuncu Yıl University, Medical Faculty Hos-
pital. The clinicopathological features of all patients were
analyzed on the basis of their medical records. Age, sex,
preoperative diagnosis, surgical procedure, location of
perforation, depth of gastric wall invasion, presence of
lymph node metastasis, presence of distant metastases
(liver metastases or intraperitoneal secondary deposits),
type of surgery, degree of lymph node dissection, type of
resection-complete (R0) or incomplete resection (R1 or
R2) – stage, and outcome of the patients were examined.
The study also assessed the impact of the preoperative
SIRS/sepsis on hospital mortality rate. Sepsis parameters
were defined according to the International Sepsis Defini-
tions Conference diagnostic criteria for sepsis [9].
These clinicopathologic findings were determined on the
basis of the general rules of American Joint Commitee on
Cancer (AJCC) [10].
Kaplan-Meir statistical analyses method was employed for
..Survival statistical analysis.
Results
The clinicopathological features of the 13 patients – 10
males and 3 females, aged from 41 to 73 years (mean,
59.0 ± 9.56) are presented in Table 1. Most cases were
advanced tumors. The incidence of perforated gastric can-
cer was 9.6% of all gastric carcinoma cases, and 4.2% of
all gastric perforation cases. Four patients presented with
sepsis before surgery. All patients underwent emergency
surgery. Malignant gastric perforation was diagnosed sub-
jectively during surgery in 11 (84.6%) patients. Among
them one patient was diagnosed from intraoperative fro-
zen section and was treated by palliative surgery due to his
poor general condition. Two patients had preoperative
diagnosis of gastric cancer. All cases were tumors that pen-
etrate serosa (3 T3 and 10 T4), and all but one patient had
metastatic lymph nodes. The disease was more frequently
in stage III–IV (2–10 cases). Only one case of stage II
(T3N0M0) gastric cancer was also observed. Surgical and
Postsurgical survival data for patients with perforated gas-
tric carcinoma are given in Table 2.
Various surgical procedures, based on the subjective
judgements of surgeons were performed. Poor general
condition, extensive tumor spread, technical difficulties in
resective procedures and severe peritonitis were the indi-
cations of the local repair. None of the patients had cura-
tive resection with radical lymph-node dissection.
Six (46%) patients with overt distal metastases or unre-
sectable direct invasion were subjectively diagnosed as
having incurable-nonresectable malignant gastric perfora-
Table 1: Clinicopathological features of patients with perforated 
gastric cancer.
Variable Number of Patients
Age
Range (yr)/Mean 41–73/59
Sex
Male 10/13
Female 3/13
Preoperative diagnosis
Perforation 11/13
Cancer 2/13
Location-Perforation side
Lower third 3/10
Middle third 5/10
Upper third 5/10
Serosal invasion
Absent 0/13
Present 13/13
Lymph node metastasis
Absent 1/13
Present 12/13
Stage of disease
I 0/13
II 1/13
III 2/13
IV 10/13
Surgery
Gastrectomy 7/13
Total 4/13
Subtotal 3/13
Local repair 6/13
Lymph node dissection
Extended (D2, D3) 0/13
Limited (D0, D1) 7/13World Journal of Emergency Surgery 2008, 3:17 http://www.wjes.org/content/3/1/17
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tion or with their poor general condition and were treated
by palliative surgery. (Simple closure or omental patch
repair, and one case treated by tube gastrostomy via perfo-
rated area of the stomach). Of these patients, two had car-
diac arrest at the induction stage of anesthesia due to their
poor general condition; after the cardiopulmonary resusi-
tation, these 2 patients had local repair and died at post-
operative care unit.
Emergency total gastrectomy was performed in 4 patients
(31%), and distal gastrectomy in 3 patients (23%). All 4
patients underwent total gastrectomy with limited lymph
node dissection including perigastric lymph nodes only.
Among this group, one patient had visceral metastases
(hepatic), one had positive proximal resection margin
and at the end of the surgery microscopic or macroscopic
(R1 or R2) residual disease was left behind in all of the
these patients.
Among the distal gastrectomy group, 2 patients under-
went surgery with macroscopic residual disease (R2) and
one without macroscopic residual disease but with only
limited lymphadenectomy due to severe peritoneal infla-
mation. This patient was recommended to undergo a sec-
ondary surgery, aiming completness of
lymphadenectomy but the patient refused to undergo
revision surgery.
As a major surgical complication; an anastomotic leakage
developed 8 days after surgery in a patient who underwent
distal gastrectomy, and the patient died from anastomotic
leakage and extensive tumoral dissemination 22 days
later.
Six patients died within the 30 days postoperatively: two
after distal and one after total gastrectomy, one after gas-
trostomy, and two after simple patch repair. The overall
30-day hospital mortality rate was 46%.
When patients were divided in to two groups according to
have sepsis or not, it was found that having preoperative
sepsis parameters was significantly correlated with 30-day
mortality. The mean survival time was shorter in septic
group compared to non-septic group (4.5 ± 4.43 days vs.
183.2 ± 200.4 days), the difference between both group
was significant. (P < 0.01)
Table 2: Postsurgical survival data for patients with perforated gastric carcinoma.
Case No Age Sex PS SI LNM TNM 
(cancer stage)
Type of surgery DLND PC Survival (days) Cause of death
1 50 M (-) (+) (+) T4N2M0-IV Total 
gastrectomy, R1 
resection
L - 180 Primary cancer
2 67 F (+) (+) (+) T4N2M1-IV Gastrostomi _ - 3 Hospital 
mortality
3 58 M (-) (+) (+) T4N2M1-IV Raphi+ Feeding 
jejunostomy
_ - 90 Primary cancer
4 51 F (-) (+) (+) T4N2M1-IV Total 
Gastrectomy
L- 7 H o s p i t a l  
mortality
5 53 M (+) (+) (+) T4N2M0-IV Raphi - - 3 Cardiac arrest at 
the induction 
stage of 
anesthesia
6 41 M (+) (+) (+) T4N2M1-IV Distal 
gastrectomy, R2 
resection
L- 1 H o s p i t a l  
mortality
7 65 M (-) (+) (+) T3N2M0-III-B Total 
gastrectomy
L - 90 Primary cancer
8 62 M (+) (+) (+) T3N1M0-III-A Raphi - - 11 Cardiac arrest at 
the induction 
stage of 
anesthesia
9 65 M (-) (+) (+) T4N2M0-IV Distal 
gastrectomy
L Anastomotic 
leakage
22 Hospital 
mortality
10 52 M (-) (+) (+) T4N2M1-IV Raphi - - 90 Primary cancer
11 57 F (-) (+) (+) T4N2M1-IV Raphi - - 120 Primary cancer
12 73 M (-) (+) (-) T3N0M0-II Distal 
gastrectomy
L - Since 09.03.2006 ALIVE
13 73 M (-) (+) (+) T4N1M0 -IV Total 
gastrectomy
L - Since 23.04.2006 ALIVE
Abbreviations: PS:Presence of sepsis, SI:Serozal invazion, LNM: Lymph node metastas, DLND:Degree of lymph node dissection, PC:Postoperative 
compications, L:Limited.World Journal of Emergency Surgery 2008, 3:17 http://www.wjes.org/content/3/1/17
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The overall survival time was 128.2 ± 184.8 days for all
patients, it was 52.8 ± 52.9 days for locally treated group,
and 192.9 ± 235.4 days for patients who underwent resec-
tional surgery. The difference between the treatment
groups was not significant. (P > 0.05)
Discussion
Perforation of gastric adenocarcinoma is rare, and sur-
geons are unlikely to encounter more than a single case in
their career. Patients with perforated gastric malignant
neoplasms usually present with histories and symptoms
that are not obviously different from those of the patients
with benign gastroduodenal or other hollow viscus perfo-
rations [6]. Preoperative diagnosis of malignancy is unu-
sual, accounting for about 30% of cases [1,3,6,11]. The
only preoperative feature that may guide the surgeon is
the age of the patient: Perforated gastric carcinoma usually
occurs in elderly patients when compared with the
patients with perforated peptic ulcers [6,12]. Similar dif-
ferences in ages were observed by other authors
[3,4,11,13]. Therefore, gastric perforation should raise
suspicions of malignancy, particularly in elderly patients
[7]. The mean age of the patients in our study is59.0 ±
9.56 years. This result is comperable to previous reports.
Preoperative diagnostic diffuculties encountered in gastric
cancer perforation continue in the operation room [7,11].
Furthermore, during the emergency operation it is often
impossible to confirm the diagnosis, particularly when a
frozen section is unavailable [6,7]. Several studies have
noted the description of 'intraoperative possible diagnosis
of gastric cancer' for those cases [5,6,11]. The histopatho-
logical diagnosis was confirmed with intraoperative fro-
zen section in only one case in the current study. The
diagnosis of cancer of two cases were already made preop-
eratively. The diagnosis of the other 10 cases could be
made with postoperative histopathological examination.
However, even if gastric cancer has been diagnosed pre- or
perioperatively, it may still be difficult to assess the true
extent of carcinoma and to determine local operability.
Inflammatory changes associated with peritonitis have led
the surgeon overestimate local tumor infiltration and the
extent of lymph-node metastases intraoperatively [12].
Based on these fact, some authors recommended two-
stage operation for PGC. In most instances the initial
operation should, therefore, be directed at the treatment
of perforation and peritonitis. After recovery of the patient
and histological confirmation of malignancy, adequate
staging can be completed and radical oncological opera-
tion for gastric cancer may be planned, if appropriate [12].
Lehnert et al. reported eight PGC patients eligible for rad-
ical surgery and two-stage operation approach had been
performed with no operative mortality and good long-
term success [12].
In contrast, in an analysis of 155 Japanese patients, Adachi
et al. [1] demonstrated that 83% of patients underwent
emergency gastrectomy with a mortality rate of 7% and 5-
year survival rate of 40%. In a case report of perforation of
advanced gastric carcinoma (with both serosal invasion
and lymph node metastasis) who underwent emergency
total gastrectomy with extended lymph node dissection
Adachi et al. reported a survival of more than 7 years [13].
Similarly, Gertsch et al. reported the ratio of emergency
gastrectomy as 88% with a mortality rate of 16%, and 6
patients were alive after a median time of 42 months [11].
With these results, they stressed that although many PGC
were advanced tumors, an emergency gastrectomy should
be the procedure of choise for the treatment. Although the
decision on whether to submit patients to gastrectomy
should be made on an individual basis, surgeon should be
aware of that gastrectomy often offer the best curative or
palliative option whenever technically feasible despite
reported hospital mortality ranging between 23% and
42% [1,5,7,13]. In the present study, we performed one-
stage gastrectomy in 7 cases. The mortality rate of the
patients who underwent resectional surgery in the present
study was 43%. This rate of mortality was somewhat
higher than those results that reported by others Recently,
Lee et al. reported 13 cases of PGC, all of them underwent
gastric resection without maortality [4].
Roviello and his colleagues concluded that if a patient has
a curable tumor and acceptable general condition, i.e. no
sign of shock, localized peritonitis and no comorbidities,
the treatment of choice seems to be radical total or subto-
tal gastrectomy with associated D2 or D3 lymphadenec-
tomy or, for a less aggressive approach, two-staged radical
gastrectomy. They also concluded that when general con-
dition is good, but the tumor is at an advanced stage with
no possibility of R0 resection, a palliative gastrectomy, if
technically possible, is recommended considering the
minor surgery-related mortality [6].
In the mentioned study, Roviello et al. also reported that;
if a pathologist is not available and histologic examina-
tion is not possible during surgery, they suggest to per-
form a gastric resection, since for perforated peptic ulcer
too the treatment of choice is resection both for the beter
morbility and the lower rate of recurrence [6].
The present study included 12 cases of stage III or IV PGC
patients, and only one case of stage II patient. This case of
stage II PGC underwent emergency distal gastrectomy
with DI lymph node dissection. After the recovery, the
patient was offered a second surgery, aiming extended,
completing lymhadenectomy, but patient refused this rec-World Journal of Emergency Surgery 2008, 3:17 http://www.wjes.org/content/3/1/17
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ommendation. The patient is still alive and disease-free.
The other 12 patients underwent emergency gastrectomies
(6 cases) with limited lymphadenectomy and incomplete
(R1 or R2) resection; and local therapies (6 cases).
In our study, the ratio of locally treated patients was high
(6 patients – 46%). The reason for this high ratio of local/
non-resectional surgery was the high frequency of
advanced stage disease.
All tumors treated with any form of local repair were at
clinical stage IV of the disease; except for one, with stage
III (T3NIM0). This patient had cardiac arrest during sur-
gery and therefore, after resuscitation, he was treated by
local surgery, and died in the postoperative period in the
intensive care unit.
This high frequency of local/non-resectional surgery was
also attributed to the poor condition of the patients, and
difficulty in resection of the malignant tissue including
perforation. Three surgery-related/hospital deaths were
observed in 6 (50%) locally treated patients. This high
ratio of hospital mortality in the locally-treated PGC cases
was also observed by different authors. Roviello reported
4 cases of PGC who had been locally treated and died after
surgery except for one case who died 5.2 months after the
operation performed for the primary disease[6].
Malignant gastric perforation is a common manifestation
of advanced cancer with serosal invasion and lymph node
metastasis[4,6]. Nevertheless, as confirmed by various
observations, gastric cancer can perforate even at an early
stage [14]. Adachi et al.[1] analyzed the surgical results of
155 patients with PGC collected from the Japanese litera-
ture finding that there were 27 stage I tumors (19%), 16
stage II tumors (12%), 42 stage III tumors (30%), and 55
stage IV tumors (39%). Similarly, the present study con-
tained solely one case of stage II patients and, 12
advanced stage PGC patients (92%).
Possible dissemination of tumor cells at the time of perfo-
ration of gastric carcinoma has been a matter of concern
[1,12]. Malignant gastric perforation is commonly
regarded as a sign of terminal disease, because it is
thought to contribute to the peritoneal dissemination of
cancer cells and early recurrence. Therefore, simple clo-
sure of the perforation has in the past been the preferred
treatment method.
However, recent reports suggest that cancer perforation
and peritoneal seeding do not necessarily influence sur-
vival in patients underwent gastrectomy [3-5,8]. The 5-
year-survival rates of many series of patients with PGC
were comparable with those of the patients with nonper-
forated gastric carcinoma [1,3,12]. In a study using multi-
variate analysis, tumor-node-metastasis stage was
demonstrated as the only factor that was correlated with
long-term survival in patients with PGC [11]. Neverthe-
less, there is a frequent belief that peritoneal contamina-
tion complicates the situation in patients with nutritional
deficiency, and immun suppression, leading to sepsis and
ileus, so that the patients get usually worse [1,11,13].
In their series, Gertsch et al.[11] also found that risk score
(poor condition of the patients) was the only variable that
was predictive of 30-day mortality among the factors such
as patients age, the location of the tumor, the size of the
tumor, depth of cancer invasion in the gastric wall and
pTNM staging. Similarly Ozmen and colleagues, Kasakura
and colleagues, and others all recently reported that,
symptoms for a longer duration and the presence of pre-
operative shock and other pre-operative complications
were the significant factors predicting the hospital mortal-
ity [3,5,8].
We also found in the present study that the PGC cases
who have had sepsis preoperatively, showed markedly
increased rate of hospital mortality when compared to the
cases without sepsis.
The rate of mortality due to surgery-related complications
in patients with PGC who undergo emergency surgery has
been reported to be as high as 11 to 16% [2,3,8]. The 30-
day hospital mortality (46%) is seems very high in the
present study. But all of this patients had seriously poor
preoperative general conditions and advanced stages of
their diseases.
This high hospital mortality ratio and unsuccessful out-
cames after PGC can be attributed to the poor condition
of patients and failure to control sepsis [1,8].
In conclusion, perforation of gastric carcinoma is a serious
complication that is observed mainly in advanced tumors.
These patients had a poor prognosis because of the pres-
ence of advanced cancer and their poor general condition.
It can be said that; thankfully, perforated gastric carci-
noma is a rare condition.
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